Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilova St., 119991, Moscow, Russia.
Gause Institute of New Antibiotics, 11 Bolshaya Pirogovskaya St., 119021, Moscow, Russia.
J Antibiot (Tokyo). 2020 Apr;73(4):236-246. doi: 10.1038/s41429-019-0273-x. Epub 2020 Jan 14.
Recently we have synthesized a set of pyrimidine nucleoside derivatives bearing extended alkyltriazolylmethyl substituents at position 5 of the nucleic base, and showed their significant activity against Mycobacterium tuberculosis virulent laboratory strain H37Rv as well as drug-resistant MS-115 strain. The presence of a lengthy hydrophobic substituent leads to the reduction of nucleoside water solubility making their antibacterial activity troublesome to study. A series of water-soluble forms of 5-modified 2'-deoxyuridines 4a-c and 8a-c were synthesized. They appeared at least two orders more soluble compared with the parent compounds 1a and 1b. Their half-hydrolysis time was 5-12 h, which can be considered optimal for prodrugs used in clinics. Obtained compounds showed moderate activity (MIC 48-95 µg·ml) against some Gram-positive bacteria including resistant strains of Staphylococcus aureus and Mycobacterium smegmatis and were low cytotoxic for human cell lines (CD >> 100 µg·ml).
最近,我们合成了一组嘧啶核苷衍生物,在核酸碱基的 5 位带有扩展的烷基三唑基甲基取代基,并显示它们对结核分枝杆菌强毒实验室株 H37Rv 以及耐药 MS-115 株具有显著的活性。长疏水性取代基的存在导致核苷水溶性降低,使得它们的抗菌活性难以研究。我们合成了一系列 5-修饰的 2'-脱氧尿苷 4a-c 和 8a-c 的水溶性形式。与母体化合物 1a 和 1b 相比,它们的溶解度至少高出两个数量级。它们的半水解时间为 5-12 小时,这可以被认为是临床用前药的最佳时间。获得的化合物对一些革兰氏阳性菌(包括耐甲氧西林金黄色葡萄球菌和耻垢分枝杆菌)具有中等活性(MIC 48-95µg·ml),并且对人细胞系的细胞毒性较低(CD>>100µg·ml)。